---
schema_version: "secwatch.filing_event.v1"
accession: "0001842952-24-000087"
form_type: "8-K"
ticker: "CNTX"
cik: "0001842952"
company_name: "Context Therapeutics Inc."
filed_at: "2024-12-23T23:59:59+00:00"
generated_at: "2026-05-28T23:47:50.073620+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Context Therapeutics sells 14.7M shares for ~$15M to MPM BioImpact

## Summary
- Sold 14,705,882 shares at ~$1.02/share for aggregate gross proceeds of ~$15M.
- Shares purchased by MPM BioImpact LLC under sales agreement with Leerink Partners dated Dec 2, 2024.
- Proceeds expected to fund working capital and general corporate purposes.

## SEC filing metadata
- accession: 0001842952-24-000087
- form_type: 8-K
- ticker: CNTX
- cik: 0001842952
- company_name: Context Therapeutics Inc.
- filed_at: 2024-12-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1842952/000184295224000087/0001842952-24-000087-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1842952/000184295224000087/cntx-20241223.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001842952-24-000087
- JSON: https://secwatch.observer/filing/0001842952-24-000087.json
- Plain text: https://secwatch.observer/filing/0001842952-24-000087.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.